is serena williams really on glp 1 Shows Off Her Figure in Swimsuit After Announcing Weight Loss from GLP-1 Serena Williams says she used

Despite the lack of consistent clinical and epidemiological evidence, the potential link between GLP-1 receptor agonists and thyroid cancer has received considerable attention

In 2023, the Indian GLP-1 market was valued at USD 105.7 million and is projected to grow at a CAGR of 27.5%, reaching approximately USD 578.9 million by 2030

doi: 10.3389/fendo.2018.00233 71 EverardABelzerCGeurtsLOuwerkerkJPDruartCBindelsLBet al

You deserve clarity before you start

Bottom line GLP-1 receptor agonist medications such as Wegovy, Saxenda, and Zepbound are FDA-approved for weight loss

September 2024: There has been an explosion of new lawsuits filed into the MDL over the last month as Ozempic litigation expands